Survival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in China

E-ISSN： 1759-7714|6|5|636-642

ISSN： 1759-7706

Source： Thoracic Cancer, Vol.6, Iss.5, 2015-09, pp. : 636-642

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Subsequent treatment of epidermal growth factor receptor‐tyrosine kinase inhibitor failure in patients with advanced lung adenocarcinoma

Thoracic Cancer, Vol. 6, Iss. 6, 2015-11 ,pp. : 678-686

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival significance of coexisting chronic obstructive pulmonary disease in patients with early lung cancer after curative surgery

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 19-24

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of calcium sensing receptor and E‐cadherin correlated with survival of lung adenocarcinoma

Thoracic Cancer, Vol. 6, Iss. 6, 2015-11 ,pp. : 754-760

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival analysis of patients with advanced non‐small cell lung cancer receiving tyrosine kinase inhibitor (TKI) treatment: A multi‐center retrospective study

Thoracic Cancer, Vol. 9, Iss. 2, 2018-02 ,pp. : 278-283

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dual drive coexistence of EML4‐ALK and TPM3‐ROS1 fusion in advanced lung adenocarcinoma

Thoracic Cancer, Vol. 9, Iss. 2, 2018-02 ,pp. : 324-327

John Wiley & Sons Inc

Access to resources Recommend Favorite